Moleculin Biotech (MBRX) Goodwill & Intangibles (2016 - 2026)

Moleculin Biotech's Goodwill & Intangibles history runs 10 years deep, the most recent figure standing at $11.1 million for Q4 2025.

• In Q4 2025, Goodwill & Intangibles changed 0.0% year-over-year to $11.1 million; the TTM figure through Dec 2025 stood at $11.1 million (changed 0.0% YoY), while the FY2025 annual figure was $11.1 million, changed 0.0% from the prior year.
• Goodwill & Intangibles for Q4 2025 stood at $11.1 million, roughly flat from $11.1 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $11.1 million in Q1 2021, with the low at $11.1 million in Q1 2021.
• The 5-year median for Goodwill & Intangibles is $11.1 million (2021), against an average of $11.1 million.
• Peak annual rise in Goodwill & Intangibles reached 0.0% in 2021, while the deepest fall reached 0.0% in 2021.
• Moleculin Biotech's Goodwill & Intangibles stood at $11.1 million in 2021, then changed by 0.0% to $11.1 million in 2022, then changed by 0.0% to $11.1 million in 2023, then changed by 0.0% to $11.1 million in 2024, then changed by 0.0% to $11.1 million in 2025.
• Business Quant data shows MBRX's Goodwill & Intangibles at $11.1 million in Q4 2025, $11.1 million in Q3 2025, and $11.1 million in Q2 2025.